Addition of oxaliplatin (Eloxatine®, LOHP) to the same leucovorin (LV) and 5 fluorouracil (5FU) bimonthly regimens after progression in patients (pts) with metastatic colorectal cancer (MCRC): Preliminary report
暂无分享,去创建一个
O. Bouché | A. Gramont | T. André | C. Louvet | F. Morvan | Y. Merrouche | V. Lucas | F. Desseigne | E. François | E. Carola | K. Beerblock | M. A. Bensmaÿne